Payden & Rygel Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Payden & Rygel Investment Group’s Portfolio BMY Stock Details BMY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$206K	Buy
2023 Q3	$221K	Buy